Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1529 record(s)

Req # A-2021-000404

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105904-139, Proposed Critical Drug Reserve Procurement Action.

Organization: Health Canada

10 page(s)
April 2024

Req # A-2023-000215

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101449-414, Review of the Fraud Risk Assessment Process at Health Canada.

Organization: Health Canada

13 page(s)
April 2024

Req # A-2023-000785

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-106521-709, Launch of the Science Competency Development Roadmap.

Organization: Health Canada

12 page(s)
April 2024

Req # A-2023-001304

Adverse Drug Reaction (ADR). Report number: E2B_06659476.

Organization: Health Canada

8 page(s)
April 2024

Req # A-2023-000589

All notes made by the Health Canada employees who reviewed the Pfizer-BioNTech Comirnaty COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.

Organization: Health Canada

0 page(s)
March 2024

Req # A-2023-000605

All notes made by the Health Canada employees who reviewed the Novavax Nuvaxovid COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2020 to December 31, 2020.

Organization: Health Canada

0 page(s)
March 2024

Req # A-2023-000832

The number of people employed by your department who have had contract service recognized since 1989 and any employment benefits they may have received, indicating the years of service, monetary value of benefits and the financial authority under…

Organization: Health Canada

0 page(s)
March 2024

Req # A-2023-001213

Screenshot of the status page for the Second Liraglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.

Organization: Health Canada

1 page(s)
March 2024

Req # A-2023-001349

Number of individuals who have filed legal claims against their doctors involuntary detaining them at a psychiatric facility.

Organization: Health Canada

0 page(s)
March 2024

Req # A-2023-001370

The names and contact information of all the people who have been officially authorized to participate in the negotiations being conducted by the Working Group for amendments to the International Health Regulations (WGIHR). All official Letters of…

Organization: Health Canada

0 page(s)
March 2024
Date modified: